By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > U.S. IPO Weekly Recap: Atmus Launches $275 Million IPO, CAVA Group Joins The Pipeline
News

U.S. IPO Weekly Recap: Atmus Launches $275 Million IPO, CAVA Group Joins The Pipeline

News
Last updated: 2023/05/21 at 3:39 PM
By News
Share
4 Min Read
SHARE

Two small deals priced this past week, neither of which were eligible for inclusion in our IPO stats, while one issuer delayed to the week ahead (AZTR). The week’s news was driven by Cummins spin-off Atmus Filtration (ATMU), which launched its $275 million IPO, and restaurant chain CAVA Group (CAVA), which filed to raise $100 million.

Projection screen maker Strong Global Entertainment (SGE) raised $4 million at a $29 million market cap. Spun out of FG Group (FGH), the company manufactures large format projection screens and provides related products and services. Strong Entertainment broke issue and finished the week down 11%.

Middle-market asset manager CaliberCos (CWD) raised just under $5 million at an $84 million market cap. The company markets its services to private investors, investment advisors, family offices and institutions, and in-house. As of December 31, 2022, it had a total fair value AUM of $745 million. After jumping in its debut, CaliberCos retreated slightly in the aftermarket, finishing up 31%.

Two companies are currently scheduled to list in the week ahead, although small issuers may join the calendar during the week.

Cummins spin-off Atmus Filtration (ATMU) is the week’s headliner, planning to raise $275 million at a $1.6 billion market cap. Primarily operating under the Fleetguard brand, the company makes various filtration products for engines and other industrial uses, which are sold in 150 countries. Atmus is profitable, and its OEM customers support recurring revenue from higher-margin aftermarket products, but its three largest customers accounted for about half of 2022 revenue.

Holdover Azitra (AZTR) plans to raise $12 million at a $70 million market cap. The biotech’s pipeline is led by a genetically modified strain of bacteria targeting orphan disease Netherton syndrome. Azitra’s lead candidate is expected to enter a Phase 1b trial in the 1H23, and the company has a joint development agreement with Bayer to develop bacterial microbes for consumer and cosmetic products.

U.S. IPO Calendar

Issuer

Business

Deal Size

Market Cap

Price Range

Shares Filed

Top

Bookrunners

Azitra (AZTR)

Branford, CT

$12M

$70M

$4.50 – $5.50

2,400,000

ThinkEquity
Phase 1-ready dermatology biotech developing engineered bacterial therapies.

Atmus Filtration (ATMU)

Nashville, TN

$275M

$1,624M

$18 – $21

14,124,409

Goldman

JPMorgan

Industrial and engine filtration business spun out of Cummins.

Street research is expected for one company in the week ahead.

IPO Market Snapshot

The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 5/18/2023, the Renaissance IPO Index was up 21.3% year-to-date, while the S&P 500 was up 10.1%. Renaissance Capital’s IPO ETF (IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Airbnb (ABNB). The Renaissance International IPO Index was down 8.1% year-to-date, while the ACWX was up 8.4%. Renaissance Capital’s International IPO ETF (IPOS) tracks the index, and top ETF holdings include Porsche (OTCPK:POAHY) and Kuaishou (OTCPK:KUASF).

Original Post

Editor’s Note: The summary bullets for this article were chosen by Seeking Alpha editors.

Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

Read the full article here

News May 21, 2023 May 21, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

QuantaSing: Letsvan To Unlock Growth; Initiate With Buy Rating

By News
News

Why U.S. Investors Are Warming To European Equities In 2025

By News
News

Autohome: AI Investments, Stock Repurchases, And Cheap (NYSE:ATHM)

By News
News

Sea Limited: Avoid Chasing The Rally Over The Cliff (NYSE:SE)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?